JP Morgan maintains Legend Biotech at neutral, cuts target to $33
JP Morgan maintained Legend Biotech at neutral and cut its price target to $33.00 from $35.00, per Benzinga’s ratings update.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.